Daignault Iyer LLP
General
Cases187
Challenger50%
Patent Owner50%
NPE50%
--
--
Practice Areas
Software, SecurityCommunicationsComp. Arch. and Software
Top Attorneys
Elite Ratings
DCTPTABCAFC
Analytics
Lawyers
Cases
Ratings Trends
Practice Areas
Recent Dockets
Entered | Case | Description |
---|---|---|
09/16/24 | REDACTED VERSION of [287] Letter, by Gerbera Therapeutics Inc., Nanjing Noratech Pharmaceutical Co., Limited. (Attachments: # [1] Exhibit G, # [2] Exhibit H, # [3] Exhibit I)(Gattuso, Dominick) (Entered: 09/16/2024) | |
09/16/24 | REPLY to Response to Motion re [17] MOTION to Dismiss Under Rule 12(b)(6) filed by Amazon Web Services Inc., Amazon.Com LLC, Amazon.Com, Inc., Audible, Inc.. (Cheek, Andrea) (Entered: 09/16/2024) | |
09/16/24 | REPLY to Response to Motion re [16] MOTION to Dismiss Under Rule 12(b)(6) filed by Amazon Web Services Inc., Amazon.Com LLC, Amazon.Com, Inc.. (Cheek, Andrea) (Entered: 09/16/2024) | |
09/16/24 | REDACTED VERSION of [1528] Letter, by Gerbera Therapeutics Inc., Nanjing Noratech Pharmaceutical Co., Limited. (Attachments: # [1] Exhibit G, # [2] Exhibit H, # [3] Exhibit I)(Gattuso, Dominick) (Entered: 09/16/2024) | |
09/16/24 | Pro Hac Vice Attorney Noorossadat Torabi for Biophore India Pharmaceuticals Private Limited and Zenara Pharma Private Limited added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (mws) (Entered: 09/16/2024) | |
09/16/24 | DEFICIENCY NOTICE by the Court issued to Gerbera Therapeutics, Inc. and Nanjing Noratech Pharmaceutical Co. Limited re [1539] Redacted Document. Upon review it was determined this filing was not a complete version of what was filed at D.I. [1528] . The redaction lacked Exhibit I. Defendants are to file a revised redacted version of D.I. [1528] no later than three (3) days from the date of this notice. (nms) (Entered: 09/16/2024) | |
09/16/24 | DEFICIENCY NOTICE by the Court issued to Gerbera Therapeutics, Inc. and Nanjing Noratech Pharmaceutical Co. Limited re [296] Redacted Document. Upon review it was determined this filing was not a complete version of what was filed at D.I. [287] . The redaction lacked Exhibit I. Defendants are to file a revised redacted version of D.I. [287] no later than three (3) days from the date of this notice. (nms) (Entered: 09/16/2024) | |
09/13/24 | BILL OF COSTS by Microsoft Corporation. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2)(Hunsaker, Kelly) (Entered: 09/13/2024) | |
09/13/24 | Motion for leave to File Sealed Document (Attachments: # 1 Proposed Order Granting Motion to Seal, # 2 SEALED DOCUMENT Motion for Attorneys' Fees, # 3 Proposed Order Granting Motion for Attorneys' Fees, # 4 Exhibit 1, # 5 SEALED DOCUMENT Exhibit 2, # 6 SEALED DOCUMENT Exhibit 3, # 7 Exhibit 4, # 8 SEALED DOCUMENT Exhibit 5, # 9 Exhibit 6) (Hunsaker, Kelly) (Entered: 09/13/2024) | |
09/10/24 | NOTICE by SoundClear Technologies LLC of Supplemental Authority (Attachments: # [1] Exhibit Exhibit A)(Sprenger, Kevin) (Entered: 09/10/2024) |